These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19828950)

  • 1. Gait and subcortical hyperintensities in mild Alzheimer's disease and aging.
    Nadkarni NK; McIlroy WE; Mawji E; Black SE
    Dement Geriatr Cogn Disord; 2009; 28(4):295-301. PubMed ID: 19828950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of subcortical hyperintensities on dual-tasking in Alzheimer disease and aging.
    Nadkarni NK; Levine B; McIlroy WE; Black SE
    Alzheimer Dis Assoc Disord; 2012; 26(1):28-35. PubMed ID: 21502852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcortical hyperintensities in Alzheimer's disease: no clear relationship with executive function and frontal perfusion on SPECT.
    Levy-Cooperman N; Lobaugh NJ; Caldwell C; Gao F; Black SE
    Dement Geriatr Cogn Disord; 2007; 24(5):380-8. PubMed ID: 17934273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial and temporal gait parameters in Alzheimer's disease and aging.
    Nadkarni NK; Mawji E; McIlroy WE; Black SE
    Gait Posture; 2009 Nov; 30(4):452-4. PubMed ID: 19740661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of brain imaging to the understanding of gait disorders in Alzheimer's disease: a systematic review.
    Annweiler C; Beauchet O; Celle S; Roche F; Annweiler T; Allali G; Bartha R; Montero-Odasso M;
    Am J Alzheimers Dis Other Demen; 2012 Sep; 27(6):371-80. PubMed ID: 22930697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings.
    Sultzer DL; Chen ST; Brown CV; Mahler ME; Cummings JL; Hinkin CH; Mandelkern MA
    J Neuropsychiatry Clin Neurosci; 2002; 14(3):262-9. PubMed ID: 12154149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison.
    Chang YT; Chang CC; Lin HS; Huang CW; Chang WN; Lui CC; Lee CC; Lin YT; Chen CH; Chen NC
    Acta Neurol Taiwan; 2012 Jun; 21(2):64-73. PubMed ID: 22879115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.
    Doddy RS; Massman PJ; Mawad M; Nance M
    Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):191-9. PubMed ID: 9845410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gait and risk of falls associated with frontal cognitive functions at different stages of Alzheimer's disease.
    Coelho FG; Stella F; de Andrade LP; Barbieri FA; Santos-Galduróz RF; Gobbi S; Costa JL; Gobbi LT
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2012 Sep; 19(5):644-56. PubMed ID: 22360785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease.
    Bocti C; Rockel C; Roy P; Gao F; Black SE
    Dement Geriatr Cogn Disord; 2006; 21(5-6):364-72. PubMed ID: 16534206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
    Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
    Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and anatomical correlates of gait dysfunction in Alzheimer's disease.
    Olazarán J; Hernández-Tamames JA; Molina E; García-Polo P; Dobato JL; Álvarez-Linera J; Martínez-Martín P;
    J Alzheimers Dis; 2013; 33(2):495-505. PubMed ID: 23011219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathological basis of magnetic resonance images in aging and dementia.
    Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC
    Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcortical nuclei in Alzheimer's disease: a volumetric and diffusion kurtosis imaging study.
    Wang ML; Wei XE; Fu JL; Li W; Yu MM; Li PY; Li WB
    Acta Radiol; 2018 Nov; 59(11):1365-1371. PubMed ID: 29482345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shape changes of the basal ganglia and thalamus in Alzheimer's disease: a three-year longitudinal study.
    Cho H; Kim JH; Kim C; Ye BS; Kim HJ; Yoon CW; Noh Y; Kim GH; Kim YJ; Kim JH; Kim CH; Kang SJ; Chin J; Kim ST; Lee KH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2014; 40(2):285-95. PubMed ID: 24413620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging.
    Fjell AM; Amlien IK; Westlye LT; Stenset V; Fladby T; Skinningsrud A; Eilsertsen DE; Bjørnerud A; Walhovd KB
    Neuroimage; 2010 Jan; 49(2):1820-30. PubMed ID: 19800012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of diffusion tensor imaging in the differential diagnosis of subcortical ischemic vascular dementia and Alzheimer's disease in patients with only mild white matter alterations on T2-weighted images.
    Fu JL; Zhang T; Chang C; Zhang YZ; Li WB
    Acta Radiol; 2012 Apr; 53(3):312-7. PubMed ID: 22416261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.